SCHEMBL9497437

SCHEMBL9497437

CC(=O)C1=CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9568927 0.82 TSHR (0.72)
Isoguvacine SCHEMBL339700 0.80
Isoguvacine SCHEMBL7958625 0.78 BLM (1.00)
Isoguvacine SCHEMBL6214170 0.78 TSHR (0.96)
SCHEMBL2032868 0.78
SCHEMBL23178983 0.78 TSHR (0.60)
SCHEMBL3019512 0.78 TSHR (0.60)
SCHEMBL15319901 0.78 TSHR (0.60)
SCHEMBL20334690 0.78 TSHR (0.60)
SCHEMBL20314991 0.78 TSHR (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0271798-B1 O-SUBSTITUTED TETRAHYDROPYRIDINE OXIME CHOLINERGIC AGENTS WARNER-LAMBERT COMPANY (US) 1993-04-07 EP claimed
US-4786648-A ANALGESIC WARNER-LAMBERT COMPANY (US) 1988-11-22 US claimed
EP-0271798-A2 O-Substituted tetrahydropyridine oxime cholinergic agents WARNER-LAMBERT COMPANY (US) 1988-06-22 EP claimed
US-20220119409-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. 2022-04-21 US disclosed
US-20200055845-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. 2020-02-20 US disclosed
WO-2018119183-A2 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. (US) 2018-06-28 WO disclosed
US-20090156572-A1 Nitrogen-containing heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED 2009-06-18 US disclosed
US-20090156572-A1 Nitrogen-containing heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED 2009-06-18 US disclosed
WO-2009072643-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-11 WO disclosed
EP-0271798-B1 O-SUBSTITUTED TETRAHYDROPYRIDINE OXIME CHOLINERGIC AGENTS WARNER-LAMBERT COMPANY (US) 1993-04-07 EP disclosed
US-4786648-A ANALGESIC WARNER-LAMBERT COMPANY (US) 1988-11-22 US disclosed
EP-0271798-A2 O-Substituted tetrahydropyridine oxime cholinergic agents WARNER-LAMBERT COMPANY (US) 1988-06-22 EP disclosed
US-4710508-A ANALGESICS WARNER-LAMBERT COMPANY (US) 1987-12-01 US disclosed